Loading…
Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice
The present study was undertaken to analyse the relationship of lens glutathione (GSH) and light to cataract development in mice deficient in γ-glutamyl transpeptidase (GGT). These mice have reduced levels of cysteine and GSH in the eye and develop cataracts. GGT-deficient mice raised under normal v...
Saved in:
Published in: | Experimental eye research 2000-12, Vol.71 (6), p.575-582 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303 |
---|---|
cites | cdi_FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303 |
container_end_page | 582 |
container_issue | 6 |
container_start_page | 575 |
container_title | Experimental eye research |
container_volume | 71 |
creator | Chévez-Barrios, Patricia Wiseman, Amy L Rojas, Emilio Ou, Ching-Nan Lieberman, Michael W |
description | The present study was undertaken to analyse the relationship of lens glutathione (GSH) and light to cataract development in mice deficient in γ-glutamyl transpeptidase (GGT). These mice have reduced levels of cysteine and GSH in the eye and develop cataracts. GGT-deficient mice raised under normal vivarium conditions, showed no cataractous changes at birth, but by 1 week they had developed nuclear opacities. By 3 weeks more severe cataracts develop, and lens GSH levels are approximately 6–7% of wild type levels. By 6–11 weeks cataracts show nuclear and cortical involvement, liquefaction and calcification. Single cell DNA electrophoresis (comet assay) demonstrated mild DNA damage in the lens epithelium. GGT-deficient mice raised in the dark beginning the day after conception all developed cataracts, but these were less severe than those in GGT-deficient mice raised with normal vivarium lighting. Administration of N -acetyl cysteine (NAC) raises lens GSH and almost completely prevents cataract development. Our data indicate that cataract development in GGT-deficient mice is multifactorial and results from exogenous damage (exposure to light), reduced lens GSH levels, and nutritional effects secondary to low cysteine levels. |
doi_str_mv | 10.1006/exer.2000.0913 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72427871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483500909138</els_id><sourcerecordid>72427871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303</originalsourceid><addsrcrecordid>eNp10EFLwzAUwPEgipvTq0cZCN46kyZrkuOYOoWJl3kOb8krRNq1Jp24z-X38DOZsqEnTyHhl5fwJ-SS0QmjtLjFTwyTnFI6oZrxIzJkVBdZ2stjMqSUiUwoPh2Qsxjf0ikXUpySAUtqqqkektkcOghgu_EdfmDVtDVuurHfjL-_skW17aDeVeNVgE1sse28g4iZw9Jb37tnb_GcnJRQRbw4rCPy-nC_mj9my5fF03y2zCwvVJdZqzkH5gQUouSClTk4rdfOMqUFUGGlVIW0zgmxVkC1y_XU5aWCUudrxSkfkZv93DY071uMnal9tFhVsMFmG43MRS6VZAlO9tCGJsaApWmDryHsDKOmj2b6aKaPZvpo6cLVYfJ2XaP744dKCVwfAEQLVZlyWB9_nRK0kCoptVeYKnz49ETsK1l0PqDtjGv8fz_4AZZRiFU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72427871</pqid></control><display><type>article</type><title>Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice</title><source>ScienceDirect Journals</source><creator>Chévez-Barrios, Patricia ; Wiseman, Amy L ; Rojas, Emilio ; Ou, Ching-Nan ; Lieberman, Michael W</creator><creatorcontrib>Chévez-Barrios, Patricia ; Wiseman, Amy L ; Rojas, Emilio ; Ou, Ching-Nan ; Lieberman, Michael W</creatorcontrib><description>The present study was undertaken to analyse the relationship of lens glutathione (GSH) and light to cataract development in mice deficient in γ-glutamyl transpeptidase (GGT). These mice have reduced levels of cysteine and GSH in the eye and develop cataracts. GGT-deficient mice raised under normal vivarium conditions, showed no cataractous changes at birth, but by 1 week they had developed nuclear opacities. By 3 weeks more severe cataracts develop, and lens GSH levels are approximately 6–7% of wild type levels. By 6–11 weeks cataracts show nuclear and cortical involvement, liquefaction and calcification. Single cell DNA electrophoresis (comet assay) demonstrated mild DNA damage in the lens epithelium. GGT-deficient mice raised in the dark beginning the day after conception all developed cataracts, but these were less severe than those in GGT-deficient mice raised with normal vivarium lighting. Administration of N -acetyl cysteine (NAC) raises lens GSH and almost completely prevents cataract development. Our data indicate that cataract development in GGT-deficient mice is multifactorial and results from exogenous damage (exposure to light), reduced lens GSH levels, and nutritional effects secondary to low cysteine levels.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1006/exer.2000.0913</identifier><identifier>PMID: 11095909</identifier><identifier>CODEN: EXERA6</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Acetylcysteine - therapeutic use ; Animals ; Biological and medical sciences ; cataract ; Cataract - drug therapy ; Cataract - enzymology ; Cataract - etiology ; cataract models ; cataractogenesis ; Cysteine - physiology ; DNA-damage ; Electrophoresis ; Free Radical Scavengers - therapeutic use ; gamma-Glutamyltransferase - deficiency ; glutathione ; Glutathione - physiology ; Lens diseases ; light damage ; Lighting ; Medical sciences ; Mice ; Mice, Inbred C57BL ; N -acetylcysteine ; Ophthalmology ; transgenic mice ; γ-glutamyl transpeptidase</subject><ispartof>Experimental eye research, 2000-12, Vol.71 (6), p.575-582</ispartof><rights>2000 Academic Press</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303</citedby><cites>FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=840678$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11095909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chévez-Barrios, Patricia</creatorcontrib><creatorcontrib>Wiseman, Amy L</creatorcontrib><creatorcontrib>Rojas, Emilio</creatorcontrib><creatorcontrib>Ou, Ching-Nan</creatorcontrib><creatorcontrib>Lieberman, Michael W</creatorcontrib><title>Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>The present study was undertaken to analyse the relationship of lens glutathione (GSH) and light to cataract development in mice deficient in γ-glutamyl transpeptidase (GGT). These mice have reduced levels of cysteine and GSH in the eye and develop cataracts. GGT-deficient mice raised under normal vivarium conditions, showed no cataractous changes at birth, but by 1 week they had developed nuclear opacities. By 3 weeks more severe cataracts develop, and lens GSH levels are approximately 6–7% of wild type levels. By 6–11 weeks cataracts show nuclear and cortical involvement, liquefaction and calcification. Single cell DNA electrophoresis (comet assay) demonstrated mild DNA damage in the lens epithelium. GGT-deficient mice raised in the dark beginning the day after conception all developed cataracts, but these were less severe than those in GGT-deficient mice raised with normal vivarium lighting. Administration of N -acetyl cysteine (NAC) raises lens GSH and almost completely prevents cataract development. Our data indicate that cataract development in GGT-deficient mice is multifactorial and results from exogenous damage (exposure to light), reduced lens GSH levels, and nutritional effects secondary to low cysteine levels.</description><subject>Acetylcysteine - therapeutic use</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>cataract</subject><subject>Cataract - drug therapy</subject><subject>Cataract - enzymology</subject><subject>Cataract - etiology</subject><subject>cataract models</subject><subject>cataractogenesis</subject><subject>Cysteine - physiology</subject><subject>DNA-damage</subject><subject>Electrophoresis</subject><subject>Free Radical Scavengers - therapeutic use</subject><subject>gamma-Glutamyltransferase - deficiency</subject><subject>glutathione</subject><subject>Glutathione - physiology</subject><subject>Lens diseases</subject><subject>light damage</subject><subject>Lighting</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>N -acetylcysteine</subject><subject>Ophthalmology</subject><subject>transgenic mice</subject><subject>γ-glutamyl transpeptidase</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp10EFLwzAUwPEgipvTq0cZCN46kyZrkuOYOoWJl3kOb8krRNq1Jp24z-X38DOZsqEnTyHhl5fwJ-SS0QmjtLjFTwyTnFI6oZrxIzJkVBdZ2stjMqSUiUwoPh2Qsxjf0ikXUpySAUtqqqkektkcOghgu_EdfmDVtDVuurHfjL-_skW17aDeVeNVgE1sse28g4iZw9Jb37tnb_GcnJRQRbw4rCPy-nC_mj9my5fF03y2zCwvVJdZqzkH5gQUouSClTk4rdfOMqUFUGGlVIW0zgmxVkC1y_XU5aWCUudrxSkfkZv93DY071uMnal9tFhVsMFmG43MRS6VZAlO9tCGJsaApWmDryHsDKOmj2b6aKaPZvpo6cLVYfJ2XaP744dKCVwfAEQLVZlyWB9_nRK0kCoptVeYKnz49ETsK1l0PqDtjGv8fz_4AZZRiFU</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Chévez-Barrios, Patricia</creator><creator>Wiseman, Amy L</creator><creator>Rojas, Emilio</creator><creator>Ou, Ching-Nan</creator><creator>Lieberman, Michael W</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001201</creationdate><title>Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice</title><author>Chévez-Barrios, Patricia ; Wiseman, Amy L ; Rojas, Emilio ; Ou, Ching-Nan ; Lieberman, Michael W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acetylcysteine - therapeutic use</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>cataract</topic><topic>Cataract - drug therapy</topic><topic>Cataract - enzymology</topic><topic>Cataract - etiology</topic><topic>cataract models</topic><topic>cataractogenesis</topic><topic>Cysteine - physiology</topic><topic>DNA-damage</topic><topic>Electrophoresis</topic><topic>Free Radical Scavengers - therapeutic use</topic><topic>gamma-Glutamyltransferase - deficiency</topic><topic>glutathione</topic><topic>Glutathione - physiology</topic><topic>Lens diseases</topic><topic>light damage</topic><topic>Lighting</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>N -acetylcysteine</topic><topic>Ophthalmology</topic><topic>transgenic mice</topic><topic>γ-glutamyl transpeptidase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chévez-Barrios, Patricia</creatorcontrib><creatorcontrib>Wiseman, Amy L</creatorcontrib><creatorcontrib>Rojas, Emilio</creatorcontrib><creatorcontrib>Ou, Ching-Nan</creatorcontrib><creatorcontrib>Lieberman, Michael W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chévez-Barrios, Patricia</au><au>Wiseman, Amy L</au><au>Rojas, Emilio</au><au>Ou, Ching-Nan</au><au>Lieberman, Michael W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>71</volume><issue>6</issue><spage>575</spage><epage>582</epage><pages>575-582</pages><issn>0014-4835</issn><eissn>1096-0007</eissn><coden>EXERA6</coden><abstract>The present study was undertaken to analyse the relationship of lens glutathione (GSH) and light to cataract development in mice deficient in γ-glutamyl transpeptidase (GGT). These mice have reduced levels of cysteine and GSH in the eye and develop cataracts. GGT-deficient mice raised under normal vivarium conditions, showed no cataractous changes at birth, but by 1 week they had developed nuclear opacities. By 3 weeks more severe cataracts develop, and lens GSH levels are approximately 6–7% of wild type levels. By 6–11 weeks cataracts show nuclear and cortical involvement, liquefaction and calcification. Single cell DNA electrophoresis (comet assay) demonstrated mild DNA damage in the lens epithelium. GGT-deficient mice raised in the dark beginning the day after conception all developed cataracts, but these were less severe than those in GGT-deficient mice raised with normal vivarium lighting. Administration of N -acetyl cysteine (NAC) raises lens GSH and almost completely prevents cataract development. Our data indicate that cataract development in GGT-deficient mice is multifactorial and results from exogenous damage (exposure to light), reduced lens GSH levels, and nutritional effects secondary to low cysteine levels.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>11095909</pmid><doi>10.1006/exer.2000.0913</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4835 |
ispartof | Experimental eye research, 2000-12, Vol.71 (6), p.575-582 |
issn | 0014-4835 1096-0007 |
language | eng |
recordid | cdi_proquest_miscellaneous_72427871 |
source | ScienceDirect Journals |
subjects | Acetylcysteine - therapeutic use Animals Biological and medical sciences cataract Cataract - drug therapy Cataract - enzymology Cataract - etiology cataract models cataractogenesis Cysteine - physiology DNA-damage Electrophoresis Free Radical Scavengers - therapeutic use gamma-Glutamyltransferase - deficiency glutathione Glutathione - physiology Lens diseases light damage Lighting Medical sciences Mice Mice, Inbred C57BL N -acetylcysteine Ophthalmology transgenic mice γ-glutamyl transpeptidase |
title | Cataract Development in γ-Glutamyl Transpeptidase-deficient Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T00%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cataract%20Development%20in%20%CE%B3-Glutamyl%20Transpeptidase-deficient%20Mice&rft.jtitle=Experimental%20eye%20research&rft.au=Ch%C3%A9vez-Barrios,%20Patricia&rft.date=2000-12-01&rft.volume=71&rft.issue=6&rft.spage=575&rft.epage=582&rft.pages=575-582&rft.issn=0014-4835&rft.eissn=1096-0007&rft.coden=EXERA6&rft_id=info:doi/10.1006/exer.2000.0913&rft_dat=%3Cproquest_cross%3E72427871%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-cc933a1d4a64f341f2ad99bdc1894a04c77867cdd44b8a09d295d2f8af92b8303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72427871&rft_id=info:pmid/11095909&rfr_iscdi=true |